Renergen Subsidiary Locks in 5-Year Take-or-Pay LNG Deal, Bringing Phase 1 to 75% Contracted
ASPI sits 17% above its 52-week low of $3.51.
Summary
Renergen signed a five-year take-or-pay LNG contract with a South African food processor, covering ~10% of Phase 1 capacity and bringing total LNG offtake to 75%. Phase 1 remains on track for Q3 2026 startup.
Key Events · M&A and Partnerships · ASPI
-
New Take-or-Pay LNG Contract Signed
Tetra4, a Renergen subsidiary, entered a five-year take-or-pay LNG sale and purchase agreement with a South African food processor at >$16/GJ, representing ~10% of Phase 1 nameplate capacity.
-
Phase 1 LNG Volumes 75% Contracted
With this contract, Renergen has now secured take-or-pay contracts for approximately 75% of the LNG volumes anticipated from Phase 1, significantly de-risking the project's revenue base.
-
Phase 1 Commercial Production on Track for Q3 2026
Phase 1 is expected to produce ~2,500 GJ/day of LNG and ~70 Mcf/day of liquid helium, with commercial production commencing in Q3 2026 and annualized revenue potential exceeding $27 million.
-
Revenue Recognition Expected in 2H 2026
ASP Isotopes expects to begin recognizing revenues from Phase 1 during the second half of 2026, providing a near-term catalyst for the company's financials.
Analysis · ASPI · Industrial Applications And Services
ASP Isotopes' Renergen subsidiary has secured another multi-year take-or-pay LNG contract, lifting Phase 1 LNG volumes to 75% contracted. This milestone de-risks the project's revenue stream ahead of the targeted Q3 2026 commercial production and bolsters the >$27 million annualized revenue projection. Priced above $16/GJ, the contract adds cash-flow visibility just as the company navigates a complex reverse merger with ENDRA Life Sciences and a $50 million private placement.
At the time of this filing, ASPI was trading at $4.10 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $509.9M. The 52-week trading range was $3.51 to $14.49. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.